Myriad Genetics (MYGN) Misses Q1 EPS by 3c
Myriad Genetics (NASDAQ: MYGN) reports Q1 EPS of $0.31, 3 cents below the analyst estimate of $0.34.
You May Also Be Interested In
- UPDATE: NetApp, Inc. (NTAP) Tops Q4 EPS by 3c; Guides Q1 Lower
- American Eagle Outfitters (AEO) Tops Q1 EPS by 3c; Guides Q2, FY12
- Auriga Maintains a 'Buy' on Myriad Genetics (MYGN); Understanding Two Areas of Concern
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
